Analytical Data
-
Gene name
C19orf52
- Application
-
Alternative Names
C19orf52; Chromosome 19 open reading frame 52; CS052_HUMAN; Uncharacterized Protein C19orf52
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BSF4
-
Expression Region
1-260aa
-
AA Sequence
MAAAALRRFWSRRRAEAGDAVVAKPGVWARLGSWARALLRDYAEACRDASAEARARPGRAAVYVGLLGGAAACFTLAPSEGAFEEALLEASGTLLLLAPATRNRESEAFVQRLLWLRGRGRLRYVNLGLCSLVYEAPFDAQASLYQARCRYLQPRWTDFPGRVLDVGFVGRWWVLGAWMRDCDINDDEFLHLPAHLRVVGPQQLHSETNERLFDEKYKPVVLTDDQVDQALWEEQVLQKEKKDRLALSQAHSLVQAEAPR
-
Molecular Weight
55.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C19orf52, also known as "chromosome 19 open reading frame 52," is a relatively uncharacterized protein that has drawn attention due to its potential roles in cellular processes and its implications in various diseases. Initial studies suggest that C19orf52 may be involved in the regulation of cellular signaling pathways and mitochondrial function, which are crucial for maintaining cellular homeostasis. Research has indicated that alterations in the expression or function of C19orf52 could be linked to several pathological conditions, including neurodegenerative diseases and cancer. Consequently, the recombinant expression of C19orf52 is pivotal for elucidating its biological functions and mechanisms. By producing the protein in a controlled laboratory environment, researchers can investigate its structural properties, interaction partners, and functional roles in vitro. Moreover, understanding the behavior of C19orf52 at the molecular level may provide insights into its contribution to disease progression and potentially uncover novel therapeutic targets. As the significance of C19orf52 continues to emerge through ongoing research, it represents an intriguing focus for scientists studying protein function, gene regulation, and disease biology. Thus, the exploration of recombinant C19orf52 is essential for advancing knowledge in both fundamental biology and clinical applications.
